Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma

Journal of Clinical Oncology

Volumn 29, Issue 15, 2011, Pages 2060-2065

  Lemma, Girum L ^a,b,c,d,e   Lee, Ju Whei ^a,b,c,d,e   Aisner, Seena C ^a,b,c,d,e   Langer, Corey J ^a,b,c,d,e   Tester, William J ^a,b,c,d,e   Johnson, David H ^a,b,c,d,e   Loehrer Sr , Patrick J ^a,b,c,d,e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; THYMOMA; THYMUS NEOPLASMS;

EID: 79956310069     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.9607     Document Type: Article

References (26)

1. Engels EA, Pfeiffer RM: Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546-551, 2003 (Pubitemid 36578561)
2. Mullen B, Richardson JD: Primary anterior mediastinal tumors in children and adults. Ann Thorac Surg 42:338-345, 1986 (Pubitemid 16013837)
3. Laurent F, Latrabe V, Lecesne R, et al: Mediastinal masses: Diagnostic approach. Eur Radiol 8:1148-1159, 1998 (Pubitemid 128662767)
4. Verstandig AG, Epstein DM, Miller WT Jr, et al: Thymoma: Report of 71 cases and a review. Crit Rev Diagn Imaging 33:201-230, 1992
5. Wilkins EW Jr, Grillo HC, Scannell JG, et al: J. Maxwell Chamberlain memorial paper: Role of staging in prognosis and management of thymoma. Ann Thorac Surg 51:888-892, 1991
6. Souadjian JV, Enriquez P, Silverstein MN, et al: The spectrum of diseases associated with thymoma: Coincidence or syndrome? Arch Intern Med 134:374-379, 1974
7. Fornasiero A, Daniele O, Ghiotto C, et al: Chemotherapy for invasive thymoma: A 13-year experience. Cancer 68:30-33, 1991
8. Loehrer PJ, Kim K, Aisner SC, et al: Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial-The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 12:1164-1168, 1994 (Pubitemid 24173929)
9. Loehrer PJ, Chen M, Kim K, et al: Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial. J Clin Oncol 15:3093-3099, 1997 (Pubitemid 27377501)
10. Berruti A, Borasio P, Gerbino A, et al: Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: A single institution experience. Br J Cancer 81:841-845, 1999 (Pubitemid 29504694)
11. Kim ES, Putnam JB, Komaki R, et al: Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report. Lung Cancer 44:369-379, 2004 (Pubitemid 38609446)
12. Bonomi PD, Finkelstein D, Aisner S, et al: EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 16:342-345, 1993 (Pubitemid 23217895)
13. Umemura S, Segawa Y, Fujiwara K, et al: A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy. Jpn J Clin Oncol 32:262-265, 2002 (Pubitemid 43102810)
14. Muller-Hermelink HK, Engel P, Kuo TT, et al: Tumors of the thymus, in Travis WD, Brambilla E, Hermelink HK, et al (eds): Pathology and Genetics: Tumors of the Lung, Pleura, Thymus and Heart - WHO Classification of Tumors. Lyon, France, IARC Press, 2004, pp 145-245
15. Macchiarini P, Chella A, Ducci F, et al: Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68: 706-713, 1991
16. Giaccone G, Ardizzoni A, Kirkpatrick A, et al: Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European Organisation for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 14:814-820, 1996
17. Loehrer PJ Sr, Jiroutek M, Aisner S, et al: Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: An intergroup trial. Cancer 91: 2010-2015, 2001
18. Igawa S, Murakami H, Takahashi T, et al: Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma. Lung Cancer 67:194-197, 2010
19. Highley MS, Underhill CR, Parnis FX, et al: Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 17:2737-2744, 1999 (Pubitemid 29415230)
20. Grassin F, Paleiron N, André M, et al: Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: A French experience. J Thorac Oncol 5:893-897, 2010
21. Umemura S, Segawa Y, Fujiwara K, et al: A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy. Jpn J Clin Oncol 32:262-265, 2002 (Pubitemid 43102810)
22. Jan N, Villani GM, Trambert J, et al: A novel second line chemotherapy treatment of recurrent thymoma. Med Oncol 14:163-168, 1997 (Pubitemid 28015592)
23. Maruyama R, Suemitsu R, Okamoto T, et al: Persistent and aggressive treatment for thymic carcinoma: Results of a single-institute experience with 25 patients. Oncology 70:325-329, 2006 (Pubitemid 46066127)
24. Masaoka A, Monden Y, Nakahara K, et al: Follow-up study of thymomas with special references to their clinical stages. Cancer 48:2485-2492, 1981 (Pubitemid 12228012)
25. Suster S, Moran CA: Thymoma, atypical thymoma, and thymic carcinoma. Am J Clin Pathol 111:826-833, 1999
26. Kondo K, Monden Y: Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 76:878-884, 2003 (Pubitemid 37100765)